Patient Pathfinder: Clinical Trials
Clinical Trials for Chronic Lymphocytic Leukemia
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 172 active Chronic Lymphocytic Leukemia trials
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia
Study Type: Interventional
The Effects of Acute and Chronic Exercise on the Immune Phenotype of Chronic Lymphocytic Leukemia Patients
Study Type: Interventional
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Study Type: Interventional Phase 1
Allo HSCT Using RIC and PTCy for Hematological Diseases
Study Type: Interventional Phase 2
Observational Study of Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors
Study Type: Observational
Pirtobrutinib and Venetoclax Combined With Minimal Residual Disease Detection for Previously Untreated Chronic Lymphocytic Leukemia, MIRACLE Study
Study Type: Interventional Phase 2
BR101801 in Adult Patients With Advanced Hematologic Malignancies( Phase I)
Study Type: Interventional Phase 1
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
Study Type: Interventional Phase 1
There are 172 active Chronic Lymphocytic Leukemia trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now